166 related articles for article (PubMed ID: 18828628)
1. Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.
Warder SE; Tucker LA; McLoughlin SM; Strelitzer TJ; Meuth JL; Zhang Q; Sheppard GS; Richardson PL; Lesniewski R; Davidsen SK; Bell RL; Rogers JC; Wang J
J Proteome Res; 2008 Nov; 7(11):4807-20. PubMed ID: 18828628
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation.
Tucker LA; Zhang Q; Sheppard GS; Lou P; Jiang F; McKeegan E; Lesniewski R; Davidsen SK; Bell RL; Wang J
Oncogene; 2008 Jun; 27(28):3967-76. PubMed ID: 18264137
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.
Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291
[TBL] [Abstract][Full Text] [Related]
4. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
7. Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor.
Wang J; Tucker LA; Stavropoulos J; Zhang Q; Wang YC; Bukofzer G; Niquette A; Meulbroek JA; Barnes DM; Shen J; Bouska J; Donawho C; Sheppard GS; Bell RL
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1838-43. PubMed ID: 18252827
[TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.
Sheppard GS; Wang J; Kawai M; Fidanze SD; BaMaung NY; Erickson SA; Barnes DM; Tedrow JS; Kolaczkowski L; Vasudevan A; Park DC; Wang GT; Sanders WJ; Mantei RA; Palazzo F; Tucker-Garcia L; Lou P; Zhang Q; Park CH; Kim KH; Petros A; Olejniczak E; Nettesheim D; Hajduk P; Henkin J; Lesniewski R; Davidsen SK; Bell RL
J Med Chem; 2006 Jun; 49(13):3832-49. PubMed ID: 16789740
[TBL] [Abstract][Full Text] [Related]
9. Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.
Wang J; Sheppard GS; Lou P; Kawai M; Park C; Egan DA; Schneider A; Bouska J; Lesniewski R; Henkin J
Biochemistry; 2003 May; 42(17):5035-42. PubMed ID: 12718546
[TBL] [Abstract][Full Text] [Related]
10. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.
Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R
Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
[TBL] [Abstract][Full Text] [Related]
12. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.
Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ
Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a dominant negative mutant of yeast methionine aminopeptidase type 2 in Saccharomyces cerevisiae.
Vetro JA; Dummitt B; Micka WS; Chang YH
J Cell Biochem; 2005 Mar; 94(4):656-68. PubMed ID: 15547949
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
Wang J; Sheppard GS; Lou P; Kawai M; BaMaung N; Erickson SA; Tucker-Garcia L; Park C; Bouska J; Wang YC; Frost D; Tapang P; Albert DH; Morgan SJ; Morowitz M; Shusterman S; Maris JM; Lesniewski R; Henkin J
Cancer Res; 2003 Nov; 63(22):7861-9. PubMed ID: 14633714
[TBL] [Abstract][Full Text] [Related]
16. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
[TBL] [Abstract][Full Text] [Related]
17. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
Endo H; Takenaga K; Kanno T; Satoh H; Mori S
J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
[TBL] [Abstract][Full Text] [Related]
18. Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.
Arico-Muendel CC; Benjamin DR; Caiazzo TM; Centrella PA; Contonio BD; Cook CM; Doyle EG; Hannig G; Labenski MT; Searle LL; Lind K; Morgan BA; Olson G; Paradise CL; Self C; Skinner SR; Sluboski B; Svendsen JL; Thompson CD; Westlin W; White KF
J Med Chem; 2009 Dec; 52(24):8047-56. PubMed ID: 19929003
[TBL] [Abstract][Full Text] [Related]
19. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies.
Weako J; Uba AI; Keskin Ö; Gürsoy A; Yelekçi K
Comput Biol Chem; 2020 Jun; 86():107244. PubMed ID: 32252002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
